Endoklinika - Company finances
|
EUR
|
2022
From: 2022-02-25
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 93,768 | 679,004 | 762,319 | 842,336 |
| Profit before tax | -17,595 | 263,956 | 186,710 | -186,579 |
| Net profit | -17,595 | 225,937 | 158,568 | -186,579 |
| Equity | 7,405 | 233,342 | 391,909 | 205,330 |
| Liabilities | 109,872 | 164,302 | 229,597 | 1,436,632 |
| Non-current assets | 68,040 | 81,060 | 130,289 | 1,491,353 |
| Current assets | 49,237 | 316,584 | 486,151 | 150,609 |
| Total assets | 117,277 | 397,644 | 616,440 | 1,641,962 |
|
Taxes paid
|
||||
| STI taxes | - | 35,148 | 83,005 | 93,720 |
| Social insurance contributions | - | 42,374 | 50,821 | 74,301 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +624.1% | +12.3% | +10.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -15.0% | 56.8% | 25.7% | -11.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -237.6% | 96.8% | 40.5% | -90.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -18.8% | 33.3% | 20.8% | -22.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -18.8% | 38.9% | 24.5% | -22.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 14.8 | 0.7 | 0.6 | 7.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 9,617 | 46,034 | 44,624 | 46,367 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Endoklinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-26 | 2026-08-27 | 687.78 |
| 2026-08-23 | 2026-08-23 | 687.78 |
| 2026-08-19 | 2026-08-19 | 687.78 |
| 2026-05-18 | 2026-05-25 | 445.64 |
| 2026-05-17 | 2026-05-17 | 7117.67 |
| 2026-03-29 | 2026-04-13 | 0.15 |
| 2026-03-17 | 2026-03-27 | 0.15 |
| 2026-03-15 | 2026-03-15 | 0.15 |
| 2026-02-18 | 2026-03-11 | 0.15 |
| 2026-01-16 | 2026-02-11 | 0.15 |
| 2026-01-01 | 2026-01-14 | 0.15 |
| 2025-12-16 | 2025-12-30 | 0.15 |
| 2025-11-18 | 2025-12-14 | 0.15 |
| 2024-08-19 | 2024-08-19 | 5039.48 |
| 2023-11-16 | 2023-12-10 | 2.61 |
| 2023-10-24 | 2023-11-13 | 2.61 |
| 2023-07-18 | 2023-07-25 | 998.82 |
Endoklinika - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Endoklinika is: 7,327 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 7326.76 |
| 2026-08-27 | 2026-08-31 | 7316.96 |
| 2026-08-18 | 2026-08-26 | 7258.3 |
| 2026-08-02 | 2026-08-07 | 4123.92 |
| 2026-07-16 | 2026-08-01 | 4090.38 |
| 2026-05-15 | 2026-05-19 | 4055.25 |
| 2026-03-02 | 2026-03-02 | 22.59 |
| 2026-01-15 | 2026-01-15 | 3977.54 |
| 2025-11-15 | 2025-11-15 | 4144.7 |
| 2025-06-19 | 2025-06-19 | 4084.55 |
| 2025-04-11 | 2025-04-14 | 2265.67 |
| 2025-03-15 | 2025-03-17 | 2262.69 |
| 2025-02-25 | 2025-02-27 | 13.81 |
| 2025-02-18 | 2025-02-24 | 2484.94 |
| 2025-02-14 | 2025-02-15 | 2254.53 |
| 2024-10-15 | 2024-10-15 | 2227.21 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Endoklinika, MB (code 306023329) is a Lithuanian small partnership engaged in general medical practice activities. In 2025, revenue reached €842.3K, up 10.5% year on year and 24.1% over two years, showing continued top-line expansion. However, profitability weakened materially: net profit turned into a €186.6K loss, compared with profit of €158.6K in 2024 and €225.9K in 2023. The 2025 net profit margin was -22.2%. Over the same period, total assets increased to €1.64M from €616.4K in 2024, driven by long-term assets of €1.49M, while short-term assets were €150.6K. Equity decreased to €205.3K from €391.9K a year earlier, and liabilities rose sharply to €1.44M. Key ratios for 2025 indicate pressure on returns and leverage, with ROE at -90.9%, ROA at -11.4%, debt-to-equity at 7.00, and asset turnover at 0.51x. Revenue per employee was €46.8K, while profit per employee was -€10.4K.